Arcadia Biosciences, Inc. — Director's Dealing 2016

Jul 20, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-07-09

Reporting Person: Ankrum Matthew A. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$8.00	2025-05-13	Common Stock (15000)	15000	Direct

Footnotes

F1: The Reporting Person resigned his position as a Director of Arcadia Biosciences, Inc. (the "Issuer") effective July 9, 2016 (the "Resignation Date"). As of the Resignation Date, the Reporting Person is no longer subject to Section 16 in connection with his transactions in the Issuer's equity securities and therefore will report only non-exempt transactions occurring within six months of opposite-way non-exempt transactions on future Forms 4 and 5. As of the Resignation Date, there were a total of 5,000 shares vested and exercisable pursuant to the Issuer's 2015 Omnibus Equity Incentive Plan and the applicable Stock Option Award Agreement. The vested options will remain exercisable for a period of ninety (90) days following the Resignation Date.